Free Trial
→ SpaceX eyes a 1.75 trillion valuation - here's what to know (From Brownstone Research) (Ad)tc pixel Free HTFL Stock Alerts

Heartflow (HTFL) Competitors

Heartflow logo
$28.32 -3.92 (-12.16%)
Closing price 04:00 PM Eastern
Extended Trading
$28.26 -0.06 (-0.21%)
As of 04:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

HTFL vs. BTSG, CELC, HIMS, CAI, and PACS

Should you buy Heartflow stock or one of its competitors? MarketBeat compares Heartflow with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Heartflow include BrightSpring Health Services (BTSG), Celcuity (CELC), Hims & Hers Health (HIMS), Caris Life Sciences (CAI), and PACS Group (PACS). These companies are all part of the "healthcare" industry.

How does Heartflow compare to BrightSpring Health Services?

Heartflow (NASDAQ:HTFL) and BrightSpring Health Services (NASDAQ:BTSG) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, valuation, profitability, risk, earnings, institutional ownership and media sentiment.

Heartflow presently has a consensus target price of $37.00, indicating a potential upside of 30.65%. BrightSpring Health Services has a consensus target price of $56.29, indicating a potential downside of 2.79%. Given Heartflow's higher possible upside, research analysts clearly believe Heartflow is more favorable than BrightSpring Health Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Heartflow
1 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.56
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
15 Buy rating(s)
2 Strong Buy rating(s)
3.12

In the previous week, Heartflow had 4 more articles in the media than BrightSpring Health Services. MarketBeat recorded 11 mentions for Heartflow and 7 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 0.67 beat Heartflow's score of 0.52 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Heartflow
2 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BrightSpring Health Services
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

BrightSpring Health Services has a net margin of 2.27% compared to Heartflow's net margin of -66.35%. BrightSpring Health Services' return on equity of 14.63% beat Heartflow's return on equity.

Company Net Margins Return on Equity Return on Assets
Heartflow-66.35% N/A -27.67%
BrightSpring Health Services 2.27%14.63%4.41%

BrightSpring Health Services has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Heartflow$176.03M13.87-$116.79M-$1.99N/A
BrightSpring Health Services$13.65B0.82$190.67M$1.4141.06

Summary

BrightSpring Health Services beats Heartflow on 11 of the 14 factors compared between the two stocks.

How does Heartflow compare to Celcuity?

Heartflow (NASDAQ:HTFL) and Celcuity (NASDAQ:CELC) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, valuation, profitability, risk, earnings, institutional ownership and media sentiment.

In the previous week, Celcuity had 1 more articles in the media than Heartflow. MarketBeat recorded 12 mentions for Celcuity and 11 mentions for Heartflow. Celcuity's average media sentiment score of 0.65 beat Heartflow's score of 0.52 indicating that Celcuity is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Heartflow
2 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Celcuity
3 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
2 Very Negative mention(s)
Positive

Celcuity has a net margin of 0.00% compared to Heartflow's net margin of -66.35%. Heartflow's return on equity of 0.00% beat Celcuity's return on equity.

Company Net Margins Return on Equity Return on Assets
Heartflow-66.35% N/A -27.67%
Celcuity N/A -203.17%-52.68%

Heartflow has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Heartflow$176.03M13.87-$116.79M-$1.99N/A
CelcuityN/AN/A-$177.04M-$3.79N/A

63.3% of Celcuity shares are owned by institutional investors. 7.7% of Heartflow shares are owned by insiders. Comparatively, 13.3% of Celcuity shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Heartflow presently has a consensus target price of $37.00, indicating a potential upside of 30.65%. Celcuity has a consensus target price of $140.20, indicating a potential upside of 1.83%. Given Heartflow's higher possible upside, research analysts clearly believe Heartflow is more favorable than Celcuity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Heartflow
1 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.56
Celcuity
1 Sell rating(s)
1 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.75

Summary

Heartflow and Celcuity tied by winning 7 of the 14 factors compared between the two stocks.

How does Heartflow compare to Hims & Hers Health?

Heartflow (NASDAQ:HTFL) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, valuation, analyst recommendations, media sentiment, earnings, risk and institutional ownership.

In the previous week, Hims & Hers Health had 64 more articles in the media than Heartflow. MarketBeat recorded 75 mentions for Hims & Hers Health and 11 mentions for Heartflow. Heartflow's average media sentiment score of 0.52 beat Hims & Hers Health's score of -0.01 indicating that Heartflow is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Heartflow
2 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Hims & Hers Health
16 Very Positive mention(s)
10 Positive mention(s)
11 Neutral mention(s)
24 Negative mention(s)
6 Very Negative mention(s)
Neutral

Hims & Hers Health has a net margin of -0.56% compared to Heartflow's net margin of -66.35%. Hims & Hers Health's return on equity of 6.10% beat Heartflow's return on equity.

Company Net Margins Return on Equity Return on Assets
Heartflow-66.35% N/A -27.67%
Hims & Hers Health -0.56%6.10%1.52%

Hims & Hers Health has higher revenue and earnings than Heartflow. Hims & Hers Health is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Heartflow$176.03M13.87-$116.79M-$1.99N/A
Hims & Hers Health$2.37B2.41$128.37M-$0.09N/A

63.5% of Hims & Hers Health shares are held by institutional investors. 7.7% of Heartflow shares are held by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Heartflow presently has a consensus target price of $37.00, suggesting a potential upside of 30.65%. Hims & Hers Health has a consensus target price of $29.50, suggesting a potential upside of 17.70%. Given Heartflow's stronger consensus rating and higher probable upside, equities analysts clearly believe Heartflow is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Heartflow
1 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.56
Hims & Hers Health
2 Sell rating(s)
11 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.12

Summary

Hims & Hers Health beats Heartflow on 9 of the 15 factors compared between the two stocks.

How does Heartflow compare to Caris Life Sciences?

Heartflow (NASDAQ:HTFL) and Caris Life Sciences (NASDAQ:CAI) are both mid-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, valuation, analyst recommendations, media sentiment, earnings, risk and institutional ownership.

In the previous week, Caris Life Sciences had 2 more articles in the media than Heartflow. MarketBeat recorded 13 mentions for Caris Life Sciences and 11 mentions for Heartflow. Heartflow's average media sentiment score of 0.52 beat Caris Life Sciences' score of 0.09 indicating that Heartflow is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Heartflow
2 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Caris Life Sciences
2 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
4 Negative mention(s)
1 Very Negative mention(s)
Neutral

Heartflow presently has a consensus target price of $37.00, suggesting a potential upside of 30.65%. Caris Life Sciences has a consensus target price of $27.56, suggesting a potential upside of 89.39%. Given Caris Life Sciences' higher probable upside, analysts clearly believe Caris Life Sciences is more favorable than Heartflow.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Heartflow
1 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.56
Caris Life Sciences
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50

Caris Life Sciences has a net margin of 3.75% compared to Heartflow's net margin of -66.35%. Caris Life Sciences' return on equity of 98.28% beat Heartflow's return on equity.

Company Net Margins Return on Equity Return on Assets
Heartflow-66.35% N/A -27.67%
Caris Life Sciences 3.75%98.28%48.87%

Caris Life Sciences has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Caris Life Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Heartflow$176.03M13.87-$116.79M-$1.99N/A
Caris Life Sciences$812.03M5.07-$68.09M-$7.61N/A

Summary

Caris Life Sciences beats Heartflow on 8 of the 12 factors compared between the two stocks.

How does Heartflow compare to PACS Group?

PACS Group (NYSE:PACS) and Heartflow (NASDAQ:HTFL) are both mid-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, earnings, risk, valuation, institutional ownership and profitability.

In the previous week, PACS Group had 1 more articles in the media than Heartflow. MarketBeat recorded 12 mentions for PACS Group and 11 mentions for Heartflow. PACS Group's average media sentiment score of 0.98 beat Heartflow's score of 0.52 indicating that PACS Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PACS Group
6 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Heartflow
2 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

PACS Group currently has a consensus price target of $45.60, suggesting a potential upside of 21.48%. Heartflow has a consensus price target of $37.00, suggesting a potential upside of 30.65%. Given Heartflow's higher possible upside, analysts clearly believe Heartflow is more favorable than PACS Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PACS Group
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.00
Heartflow
1 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.56

PACS Group has a net margin of 4.49% compared to Heartflow's net margin of -66.35%. PACS Group's return on equity of 26.47% beat Heartflow's return on equity.

Company Net Margins Return on Equity Return on Assets
PACS Group4.49% 26.47% 4.36%
Heartflow -66.35%N/A -27.67%

PACS Group has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PACS Group$5.29B1.12$191.54M$1.5624.06
Heartflow$176.03M13.87-$116.79M-$1.99N/A

Summary

PACS Group beats Heartflow on 11 of the 14 factors compared between the two stocks.

Get Heartflow News Delivered to You Automatically

Sign up to receive the latest news and ratings for HTFL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HTFL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HTFL vs. The Competition

Export
MetricHeartflowHealth Information Services IndustryMedical SectorNASDAQ Exchange
Market Cap$2.44B$299.00M$6.23B$12.27B
Dividend YieldN/A5.59%2.80%5.35%
P/E Ratio-14.23173.4220.1425.23
Price / Sales13.87122.94542.4473.19
Price / CashN/A47.1443.2656.33
Price / Book8.025.279.816.90
Net Income-$116.79M-$22.78M$3.56B$333.88M
7 Day Performance-4.03%-1.12%0.33%0.04%
1 Month Performance-3.11%-4.53%-0.98%1.74%
1 Year PerformanceN/A-11.74%36.19%32.64%

Heartflow Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HTFL
Heartflow
3.3266 of 5 stars		$28.32
-12.2%		$37.67
+33.0%		N/A$2.44B$176.03MN/A699
BTSG
BrightSpring Health Services
3.2887 of 5 stars		$52.94
+0.4%		$56.29
+6.3%		+148.6%$10.27B$12.91B37.5523,500
CELC
Celcuity
1.7527 of 5 stars		$130.71
-6.3%		$134.50
+2.9%		+1,140.5%$6.32BN/AN/A40
HIMS
Hims & Hers Health
3.8159 of 5 stars		$25.68
-4.5%		$31.86
+24.1%		-60.8%$5.85B$2.35B50.352,442
CAI
Caris Life Sciences
4.3105 of 5 stars		$19.84
+3.7%		$28.86
+45.4%		N/A$5.61B$812.03MN/A1,846

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:HTFL) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel